Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ekimoto

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1997
[Our policy and future tasks related to ICH in anti-cancer drug development--a discussion from the viewpoint of an enterprise]H Ekimoto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1985
[Experimental studies on combination chemotherapy of cisplatin with peplomycin against human squamous cell carcinomas in nude mice]H Ekimoto, M Aikawa, K Takahashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1989
[Combination effects of etoposide with other antitumor drugs in vitro and in vivo]K Nishikawa, K Kusama, H Ekimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 9, 1999
[Evaluation of antitumor activity of etoposide administered orally for 21 consecutive days against human uterine cancer subcutaneous and/or orthotopic xenografts in nude mice]S Matsumoto, H Mashiba, K Okamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1984
[Changes of anticancer activity and pulmonary toxicity of bleomycins in differences of administration schedules and routes in mice]H Ekimoto, K Takahashi, A Matsuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1983
[Experimentally induced bleomycin pulmonary toxicity--comparison of the systemic (intraperitoneal) and local (intratracheal) administration]H Ekimoto, K Takahashi, A Matsuda, et al.
Nihon Gan Chiryo Gakkai Shi|April 20, 1989
[Effects of anti-platelet aggregating agents on peplomycin induced pulmonary toxicity in mice]M Okada, H Ekimoto, J Ito, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1990
[Experimental combination chemotherapy of YNK01, a novel analog of cytarabine, with other antitumor agents]T Uchida, T Nagahata, M Arakawa, et al.
The Journal of Antibiotics|April 1, 1980
Kinetics of the reaction of bleomycin-Fe(II)-O2 complex with DNAH Ekimoto, H Kuramochi, K Takahashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1991
[Antitumor activity by long-term administration of low-dose etoposide]K Kusama, H Ekimoto, T Ishii, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1997
[Our policy and future tasks related to ICH in anti-cancer drug development--a discussion from the viewpoint of an enterprise]H Ekimoto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1985
[Experimental studies on combination chemotherapy of cisplatin with peplomycin against human squamous cell carcinomas in nude mice]H Ekimoto, M Aikawa, K Takahashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1989
[Combination effects of etoposide with other antitumor drugs in vitro and in vivo]K Nishikawa, K Kusama, H Ekimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 9, 1999
[Evaluation of antitumor activity of etoposide administered orally for 21 consecutive days against human uterine cancer subcutaneous and/or orthotopic xenografts in nude mice]S Matsumoto, H Mashiba, K Okamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1984
[Changes of anticancer activity and pulmonary toxicity of bleomycins in differences of administration schedules and routes in mice]H Ekimoto, K Takahashi, A Matsuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1983
[Experimentally induced bleomycin pulmonary toxicity--comparison of the systemic (intraperitoneal) and local (intratracheal) administration]H Ekimoto, K Takahashi, A Matsuda, et al.
Nihon Gan Chiryo Gakkai Shi|April 20, 1989
[Effects of anti-platelet aggregating agents on peplomycin induced pulmonary toxicity in mice]M Okada, H Ekimoto, J Ito, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1990
[Experimental combination chemotherapy of YNK01, a novel analog of cytarabine, with other antitumor agents]T Uchida, T Nagahata, M Arakawa, et al.
The Journal of Antibiotics|April 1, 1980
Kinetics of the reaction of bleomycin-Fe(II)-O2 complex with DNAH Ekimoto, H Kuramochi, K Takahashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1991
[Antitumor activity by long-term administration of low-dose etoposide]K Kusama, H Ekimoto, T Ishii, et al.
Pageof 4